Hana Pharm Co Ltd (293480) - Total Liabilities

Latest as of September 2025: ₩98.98 Billion KRW ≈ $67.08 Million USD

Based on the latest financial reports, Hana Pharm Co Ltd (293480) has total liabilities worth ₩98.98 Billion KRW (≈ $67.08 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Hana Pharm Co Ltd cash flow conversion to assess how effectively this company generates cash.

Hana Pharm Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Hana Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 293480 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Hana Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hana Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Molson Coors Beverage Company NYSE:TAP-A	USA	$12.20 Billion
ELK-Desa Resources Bhd KLSE:5228	Malaysia	RM412.26 Million
TuHURA Biosciences Inc NASDAQ:HURA	USA	$6.42 Million
Siam Pan Group PCL BK:SPG	Thailand	฿457.05 Million
Zeotech Ltd AU:ZEO	Australia	AU$1.91 Million
Action SA WAR:ACT	Poland	zł314.76 Million
Sun Yad Construction Co Ltd TW:1316	Taiwan	NT$11.35 Billion
Turker Proje Gayrimenkul Ve Yatirim Gelistirme AS IS:TURGG	Turkey	TL583.33 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Hana Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 293480 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hana Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hana Pharm Co Ltd (2016–2024)

The table below shows the annual total liabilities of Hana Pharm Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩72.83 Billion ≈ $49.36 Million	+3.46%
2023-12-31	₩70.40 Billion ≈ $47.71 Million	-9.24%
2022-12-31	₩77.57 Billion ≈ $52.57 Million	+50.34%
2021-12-31	₩51.60 Billion ≈ $34.97 Million	+16.74%
2020-12-31	₩44.20 Billion ≈ $29.95 Million	+3.50%
2019-12-31	₩42.70 Billion ≈ $28.94 Million	+15.43%
2018-12-31	₩36.99 Billion ≈ $25.07 Million	-38.60%
2017-12-31	₩60.25 Billion ≈ $40.83 Million	+1.94%
2016-12-31	₩59.11 Billion ≈ $40.06 Million	--

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$115.01 Million

₩169.71 Billion KRW

Market Cap Rank

#18657 Global

#964 in Korea

Share Price

₩9810.00

Change (1 day)

-1.11%

52-Week Range

₩9090.00 - ₩12430.00

All Time High

₩26028.86